Lupin and Takeda to commercialise Vonoprazan in India

Lupin has announced a non-exclusive patent licence agreement with Takeda for the commercialisation of Vonoprazan Tablets in India.

Sep 20, 2024 - 04:00

Lupin and Takeda to commercialise Vonoprazan in India

Lupin has announced a non-exclusive patent licence agreement with Takeda for the commercialisation of Vonoprazan Tablets in India.

Read the original article

Tags:

Previous Article

Organon makes $1.2bn play for Roivant’s immuno-dermatology subsidiary

FDA approves Accord BioPharma’s HERCESSI for cancer treatment

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

To fight bias against people with addiction, White House calls for ‘recovery-friendly’ workplaces

To fight bias against people with addiction, White Hous...

Nov 9, 2023

Senate confirms Monica Bertagnolli as NIH director

Senate confirms Monica Bertagnolli as NIH director

Nov 7, 2023

Opinion: Gain-of-function research is about much more than dangerous pathogens

Opinion: Gain-of-function research is about much more t...

Jul 22, 2023